bicalutamide and Overweight

bicalutamide has been researched along with Overweight in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bilusic, M; Dahut, WL; Donahue, RN; Geynisman, DM; Ghatalia, P; Gulley, JL; Karzai, F; Madan, RA; Plimack, ER; Ross, EA; Schlom, J; Toney, NJ; Wroblewski, S; Zibelman, M	1

Trials

1 trial(s) available for bicalutamide and Overweight

Article	Year
A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1). Prostate cancer and prostatic diseases, 2022, Volume: 25, Issue:4 Topics: Androgen Antagonists; Anilides; Humans; Male; Metformin; Nitriles; Obesity; Overweight; Programmed Cell Death 1 Receptor; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Tosyl Compounds	2022

Article

Year

A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1).

Prostate cancer and prostatic diseases, 2022, Volume: 25, Issue:4

Topics: Androgen Antagonists; Anilides; Humans; Male; Metformin; Nitriles; Obesity; Overweight; Programmed Cell Death 1 Receptor; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Tosyl Compounds

2022